Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,410 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 32 locations
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute ( Site 0090) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers ( Site 0036) Chandler, Arizona, United States
  • City of Hope ( Site 0097) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0099) Irvine, California, United States
View all 270 locations
View Trial Details
Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NCT06774963

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, +37 more
Locations
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
View all 14 locations
View Trial Details
Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology/Oncology - Parkside Santa Monica, California, United States
View all 89 locations
View Trial Details
Recruiting

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

NCT06764940

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +10 more
Locations
  • City of Hope--Duarte Duarte, California, United States
  • Univ. of California Los Angeles Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
  • University Of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
View Trial Details

Related conditions